Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods.
News-Medical.Net on MSN
AI turns routine pathology slides into powerful maps of the tumor immune landscape
A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...
The NAO found the current cost of supporting people seeking asylum is “disproportionately high” and totalled around £4.9 ...
A detailed look at last year’s CBSE AI Board Exam paper, including Section A and Section B questions, marking scheme, and ...
Morning Overview on MSN
Hubble revisits 3I/ATLAS, and the results are surprising
Interstellar visitor 3I/ATLAS has returned to Hubble’s field of view, and the fresh images are forcing astronomers to rethink ...
Morning Overview on MSN
Surge AI’s CEO fears companies are optimizing for AI slop
Corporate enthusiasm for generative AI has collided with a harsher reality: the internet is filling up with low-value, ...
In a remarkable collaboration, residents of Brunswick, Georgia, have joined forces with scientists and faith leaders to ...
With whole striploin competition entries worth anything up to $2000 each, the stakes could not have been higher in Australia’s toughest and arguably most prestigious branded beef competition evaluated ...
AI can’t be bought off the shelf. Here's how data strategy, pragmatic AI planning and skilled teams form the integrated ...
Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque . ProMIS on track to complete enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results